CorMedix Inc. reported $462M of revenue over the trailing twelve months, +281% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $462M (to Q2 2026). Net income: $187M, trailing twelve months to Q2 2026. Free cash flow: $250M, trailing twelve months to Q2 2026. Operating margin: 47%, trailing twelve months to Q2 2026.

CRMDCorMedix Inc.

Healthcare

$7.31-34% 1Y

$7.31

$6.2552 weeks$12.73

CRMD as reported

CorMedix Inc. reported $462M of revenue over the trailing twelve months, +281% on the year before. 10 reported series are charted on this page, each one as filed.

$462M

Revenue, trailing twelve months · to Q2 2026 · +281% against the twelve months before

Net income: $187M
Net income · +266% year on year · trailing twelve months to Q2 2026
Free cash flow: $250M
Free cash flow · +724% year on year · trailing twelve months to Q2 2026
Operating margin: 47%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for CRMD, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$462M	+281%	Q2 2026
Net income	$187M	+266%	Q2 2026
EPS	$2.05	+166%	Q2 2026
Gross margin	83%	n/a	Q2 2026
Operating margin	47%	n/a	Q2 2026
Net margin	43%	n/a	Q2 2026
ROE	41%	n/a	Q2 2026
ROA	21%	n/a	Q2 2026
Free cash flow	$250M	+724%	Q2 2026
P/E	3.57	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.